D+70
* All sessions will be presented in English.
* KOR : Korean session
| DAY1 @ Grand Hall 1 (B1) | ||
|---|---|---|
| 09:00~10:20 |
Symposium 1 Novel Approaches to Conquer Cardiorenal Diseases |
|
| Chairperson(s) : | Seung Hwan Han (Gachon Univ.) Hoon Suk Park (The Catholic Univ.) |
|
| 09:00~09:15 | Aldosterone Synthase Inhibitors vs Aldosterone Receptor Antagonists in CKD | Soo-Young Yoon (Kyung Hee Univ.) |
| 09:15~09:30 | Endothelin Receptor Antagonists in Diabetic and Non-Diabetic Chronic Kidney Disease | Shina Lee (Ewha Womans Univ.) |
| 09:30~09:45 | GLP-1RA, GIP, and Glucagon Triple | Se Hee Min (Ulsan Univ.) |
| 09:45~10:00 | Optimizing Anticoagulation Strategies in CKD and ESRD Patients with Atrial Fibrillation | Youngjin Cho (Seoul National Univ.) |
| 10:00~10:20 | Discussion |
Dae young Cheon (Hallym Univ.) Sung-Hwan Kim (Ulsan Univ.) Wonjin Kim (CHA Univ.) Young Youl Hyun (Sungkyunkwan Univ.) |
| 10:20~10:40 | Coffee Break, Poster Presentation & Exhibition | |
| 10:40~10:50 | Opening Remark | Young Keun On (Sungkyunkwan Univ.) |
| 10:50~11:40 | Plenary Lecture 1 | |
| Chairperson(s) : | Sang Hong Baek (The Catholic Univ.) | |
| 10:50~11:40 | From Biology to New Biotherapeutics : Resistin-Blocking Antibody for the Inflammatory Diseases | Hyo-Soo Kim (Seoul National Univ.) |
| 11:40~12:10 |
Luncheon Symposium 1
|
|
| Chairperson(s) : |
Jae-Joong Kim (Ulsan Univ.) Sang-Hyun Kim (Seoul National Univ.) |
|
| 11:40~12:10 | How Is Carvedilol Different From Other Beta Blockers: β-Blockers & Beyond | Ji-Hun Jang (Inha Univ.) |
| 12:10-12:50 | Lunch, Poster Presentation & Exhibition | |
| 12:50~14:10 |
Symposium 3 Cardiovascular Pharmacotherapy in Primary Prevention |
|
| Chairperson(s) : | Hyo-Soo Kim (Seoul National Univ.) Junghyun Noh (Inje Univ.) |
|
| 12:50~13:05 | From Glucose to Plaque: Expanding the Role of GLP-1 Receptor Agonists | Moon-Seung Soh (Ajou Univ.) |
| 13:05~13:20 | Beyond Glucose Control: SGLT2 Inhibitors for Organ Protection in Primary Prevention | Bong-Joon Kim (Kosin Univ.) |
| 13:20~13:35 | Revisiting Aspirin in Primary Prevention: Still Useful in Selected Patients? | Ji-Hun Jang (Inha Univ.) |
| 13:35~13:50 | PCSK9 Inhibition in Primary Prevention: Where Do We Draw the Line? | Hyo-Suk Ahn (The Catholic Univ.) |
| 13:50~14:10 | Discussion |
Hyun-Jin Kim (Hanyang Univ.) Jae Bin Seo (Seoul National Univ.) Jaehoon Chung (Dongguk Univ.) Sang Min Park (Eulji Univ.) |
| 14:10~15:00 | Plenary Lecture 2 | |
| Chairperson(s) : | Young Keun On (Sungkyunkwan Univ.) | |
| 14:10~15:00 | Cardiovascular Regeneration Therapy Using Adipose-Derived Regenerative Cells (ADRC) | Toyoaki Murohara (Nagoya Univ., Japan) |
| 15:00~15:20 | Coffee Break, Poster Presentation & Exhibition | |
| 15:20~16:40 |
Symposium 5 Grand Debates: 1. Statins' Pleiotropic Effect, 2. PCI + OMT vs. OMT in Stable CAD |
|
| Chairperson(s) : | Hyo-Soo Kim (Seoul National Univ.) Sang-Hyun Kim (Seoul National Univ.) |
|
| 15:20~15:35 | Presence of Pleiotropic Effect of Statin: PROS | Kang-Un Choi (Yeungnam Univ.) |
| 15:35~15:50 | Presence of Pleiotropic Effect of Statin: CONS | Dae young Cheon (Hallym Univ.) |
| 15:50~16:05 | PCI for Stable Angina: Favored | Joo Myung Lee (Sungkyunkwan Univ.) |
| 16:05~16:20 | OMT Alone for Stable Angina Is Enough | Gyu-Chul Oh (The Catholic Univ.) |
| 16:20~16:40 | Discussion |
Bon-Kwon Koo (Seoul National Univ.) Jung-Sun Kim (Yonsei Univ.) Sung Kee Ryu (Ewha Womans Univ.) Toyoaki Murohara (Nagoya Univ., Japan) |
| 16:40-17:10 | Featured Lecture 1 | |
| Chairperson(s) : | Dae Hyeok Kim (Inha univ.) | |
| 16:40-17:10 | AI for Protein Structure Prediction and Antibody Design | Chaok Seok (Seoul National Univ.) |
| 17:10-17:40 |
Satellite Scientific session 1
|
|
| Chairperson(s) : | Young Keun On (Sungkyunkwan Univ.) | |
| 17:10-17:25 | Unique Anti-Arrhythmic Effect of Carvedilol SR: Be Able to Label | Chang Hee Kwon (Konkuk Univ.) |
| 17:25-17:40 | Optimizing Anticoagulation Strategies in NVAF Patients with Diabetes: A Comprehensive Approach | Daehoon Kim (Yonsei Univ.) |
| DAY1 @ Grand Hall 4+5 (B1) | ||
|---|---|---|
| 09:00~10:20 |
Symposium 2 Use of Appropriate Cardiovascular Medications in Pregnant and Lactating Women |
|
| Chairperson(s) : |
Myung-A Kim (Seoul National Univ.) Mi-Seung Shin (Gachon Univ.) |
|
| 09:00~09:15 | Safe Use of Antihypertensive Drugs During Pregnancy and Breastfeeding | SungA Bae (Yonsei Univ.) |
| 09:15~09:30 | Lipid-Lowering Therapies in Pregnancy and Lactation | Jaehoon Chung (Dongguk Univ.) |
| 09:30~09:45 | Antiplatelet and Anticoagulant Agents | Darae Kim (Sungkyunkwan Univ.) |
| 09:45~10:00 | Anti-Diabetic Agents | Joon Ho Moon (Seoul National Univ.) |
| 10:00-10:20 | Discussion |
Hyun Ju Yoon (Chonnam National Univ.) Seung Mi Lee (Seoul National Univ.) Yong-Hyun Kim (Korea Univ.) Youngsup Byun (Inje Univ.) |
| 10:20~10:40 | Coffee Break, Poster Presentation & Exhibition | |
| 10:40~10:50 | Opening Remark | Young Keun On (Sungkyunkwan Univ.) |
| 10:50~11:40 | Parallel Session in Grand Hall 1 only | |
| 11:40~12:10 |
Luncheon Symposium 2
|
|
| Chairperson(s) : | Hae-ok Jung (The Catholic Univ.) Jooyong Hahn (Sungkyunkwan Univ.) |
|
| 11:40~12:10 | AMOPREL®: A Novel Therapeutic Option for Hypertension Management | SungA Bae (Yonsei Univ.) |
| 12:10-12:50 | Lunch, Poster Presentation & Exhibition | |
| 12:50~14:10 |
Symposium 4 Low-Dose Combination vs Full-Dose One Drug: Rationale and Evidence |
|
| Chairperson(s) : |
Koji Hasegawa (Kyoto National Medical Center, Japan) Sungha Park (Yonsei Univ.) |
|
| 12:50~13:05 | In Hypertension Treatment | Heesun Lee (Seoul National Univ.) |
| 13:05~13:20 | In Dyslipidemia Treatment | Han Na Jung (Hallym Univ.) |
| 13:20~13:35 | In Heart Failure Treatment | Sang Eun Lee (Ulsan Univ.) |
| 13:35~13:50 | In Diabetes Treatment | Wonjin Kim (CHA Univ.) |
| 13:50~14:10 | Discussion |
Eung Ju Kim (Korea Univ.) Jin-Joo Park (Seoul National Univ.) Jung Hyun Choi (Pusan National Univ.) Se Eun Park (Sunkyunkwan Univ.) |
| 14:10~15:00 | Parallel Session in Grand Hall 1 only | |
| 15:00~15:20 | Coffee Break, Poster Presentation & Exhibition | |
| 15:20~16:40 |
Symposium 6 Pharmacotherapy in Intensive Care Medicine |
|
| Chairperson(s) : | Young-Hoon Jeong (Chung-Ang Univ.) Jeong Hoon Yang (Sungkyunkwan Univ.) |
|
| 15:20~15:35 | Inotropes/Vasopressors | Dae-Hwan Bae (Bucheon Sejong Hospital) |
| 15:35~15:50 | Antiarrhythmics | Sung-Hwan Kim (Ulsan Univ.) |
| 15:50~16:05 | Sedatives & Analgesics | Jin Wi (Gachon Univ.) |
| 16:05~16:20 | Considerations in the Elderly | Haechan Cho (Seoul National Univ.) |
| 16:20~16:40 | Discussion |
Ji Hyun Cha (Samsung Medical Center) Jong-Shin Woo (Kyung Hee Univ.) Kyung-Hee Kim (Incheon Sejong Hospital) Sang-Ho Park (Soonchunhyang Univ.) |
| 16:40-17:10 | Featured Lecture 2 | |
| Chairperson(s) : | Sang-Ho Jo (Hallym Univ.) | |
| 16:40-17:10 | Next-Generation AI for Model-Informed Drug Development: From Prediction to Decision | Min Jung Chang (Yonsei Univ.) |
| 17:10-17:40 |
Satellite Scientific session 2
|
|
| Chairperson(s) : | Sung Kee Ryu (Ewha Womans Univ.) | |
| 17:10-17:25 | Pulmonary Arterial Hypertension: From Diagnosis to Optimized Treatment with Maciten™ | Sung-Hee Shin (Inha Univ.) |
| 17:25-17:40 | Start the Journey of Hypertension Care with TRUSET® Low-Dose | SungA Bae (Yonsei Univ.) |
| Grand Hall 2+3 (B1) Exhibition Hall | ||
|---|---|---|
| ZONE A | ||
| Chairperson(s) : | Jong-Shin Woo (Kyung Hee Univ.) | |
| Reviewer : |
Gyu-Chul Oh (The Catholic Univ., Korea), Jaehoon Chung (Dongguk Univ.) |
|
| Presentation: 3 minutes, Q&A: 2 minutes | ||
| 12:10-12:15 | (ABST-0044) Direct Oral Anticoagulant-Related Bleeding in the Emergency Department: A Three-Year Retrospective Study at King Chulalongkorn Memorial Hospital, Thai Red Cross Society | Kanyarat Susantitapong (King Chulalongkorn Memorial Hospital, Thailand) |
| 12:15-12:20 | (ABST-0072) Effectiveness of Edible Bird Nest in Improving Cardiovascular Risk Profile Among Premenopausal Women: A Randomised Controlled Trial | Salwana Ahmad (Universiti Putra, Malaysia) |
| 12:20-12:25 | (ABST-0068) Global Variations in Statin Eligibility for Primary ASCVD Prevention: A Scoping Review of Major Guidelines (2018–2025) | Meiza Fadhila Azzahra (RSUD dr. Soehadi Prijonegoro Sragen, Indonesia) |
| 12:25-12:30 | (ABST-0041) Cardioprotective effects of β-lapachone against isoproterenol-induced cardiac hypertrophy and dysfunction | Trong Kha Pham (Inje Univ., Vietnam) |
| 12:30-12:35 | (ABST-0037) Drug Utilization Review of Non-vitamin K Antagonist Oral Anticoagulants and Factors Influencing Clinical Outcomes in Hospitals Under Bangkok Metropolitan Administration | Usasiri Srisakul (Siam Univ., Thailand) |
| 12:35-12:40 | (ABST-0025) Bridging the Gap in Nutritional Care: Lessons from a Surgical Ward Audit | Zalina Abu Zaid (Senior Lecturer, Malaysia) |
| 12:40-12:45 | (ABST-0050) Impact of 2nd-Generation versus 3rd-Generation β-Blocker Prescription at Discharge on Long-term Clinical Outcomes in ST elevation Myocardial Infarction Patients with Preserved Left Ventricular Ejection Fraction (≥50%) treated with Drug-eluting Stents | Manda Satria Chesario (Korea Univ.) |
| ZONE B | ||
| Chairperson(s) : | Jae Bin Seo (Seoul National Univ.) | |
| Reviewer : | Jin-Joo Park (Seoul National Univ.), Sung-Hee Shin (Inha Univ.) | |
| Presentation: 3 minutes, Q&A: 2 minutes | ||
| 12:10-12:15 | (ABST-0036) CardioLLM: A Multimodal Clinical Language Model for Cardiovascular Disease Diagnosis and Risk Assessment | Rao Faizan (Kyung Hee Univ., Pakistan) |
| 12:15-12:20 | (ABST-0059) The Impact of Glucagon-Like Peptide-1 Receptor Agonists, And Modification Life Style On HbA1c, Visceral Fat Area, And Body Fat Mass Type 2 Diabetes Mellitus Patients | Elfina Rachmi (Mganikcare Diabetes Metabolic Centre, Indonesia) |
| 12:20-12:25 | (ABST-0073) BH4 rescues the cardiomyopathic phenotype in rodent models of diabetes by activating CaMKK2/CREB/PGC-1α signaling pathway | Hoai To Thi Nguyen (Inje Univ., Vietnam) |
| 12:25-12:30 | (ABST-0071) Prevalence and determinants of obesity among patients undergoing haemodialysis in Malaysia | Nurfaizah Saibul (Universiti Putra, Malaysia) |
| 12:30-12:35 | (ABST-0034) Suitable Intensity of International Normalized Ratio (INR) in Thai Patients with Mitral Valve Stenosis Receiving Warfarin: a High-Risk Thromboembolism Subgroup Analysis | Punyawee Puchsaka (Siam Univ., Thailand) |
| 12:35-12:40 | (ABST-0049) Impact of β-Blocker Nebivolol versus Carvedilol Prescription at Discharge on Long-term Clinical Outcomes in ST elevation Myocardial Infarction Patients with Reduced Left Ventricular Ejection Fraction (<40%) treated with Drug-eluting Stents | Melly Susanti (Korea Univ.) |
| 12:40-12:45 | (ABST-0040) Artificial Intelligence Driven Digital Health Platform for Predicting Heart Failure Decompensation Using Wearable and Clinical Data | Rao Faizan (Kyung Hee Univ., Pakistan) |